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Abstract
 
Erectile dysfunction (ED) is the subject of a vast clinical literature, but little information has been gathered from random samples of
the general public. The Massachusetts Male Aging Study (MMAS) addressed this important aspect of men’s health. The MMAS was con-
ducted in two waves, with baseline data collection in 1987–1989 and follow-up in 1995–1997. Subsequent to the baseline MMAS survey, a
consensus developed that subjective measures are optimal for defining ED. Unfortunately, the baseline questionnaire did not ask subjects
directly about their erectile functioning. Thus, we previously assigned the MMAS subjects a degree of impotence at baseline using a series
of related questions, employing a discriminant formula constructed from a separate sample of urology clinic patients. At follow-up the
men classified themselves directly in addition to answering the original series of related questions. In the present article, we report the re-
sults of a new discriminant function, based on the MMAS men at follow-up. We also compare the two methods and discuss our reasons
for preferring the internally calibrated method. © 2000 Elsevier Science Inc. All rights reserved.
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1. Introduction
 
Erectile dysfunction (ED) is the subject of a vast clinical
literature, but little available information on the epidemiol-
ogy of the condition is based on random samples of commu-
nity-dwelling individuals. The Massachusetts Male Aging
Study (MMAS) addressed this important aspect of men’s
health through a population-based sampling frame, conducting
in-person interviews in the subjects’ homes. The MMAS was a
cohort study conducted in two waves, with baseline data col-
lection in 1987–1989 and follow-up in 1995–1997.
The common term “impotence” has been replaced in the
last 5 years by “erectile dysfunction” at the urging of a Na-
tional Institutes of Health consensus panel that convened in
1992, halfway between the two waves of the MMAS. The
panel published a working definition of ED [1]—“the per-
sistent inability to attain and maintain a penile erection ade-
quate for satisfactory sexual performance”—and called for
“major research efforts” to improve diagnostic classifica-
tion for epidemiologic purposes. It bears emphasizing that
this definition is based on a subjectively identified state for
each man that depends on his perception of satisfactory sex-
ual performance.
It was left to the research community to operationalize
the NIH consensus definition in further studies. Clinical
questionnaires have been developed (e.g. [2, 3]), but asking
sensitive questions in a primary provider’s office, once the
patient has sought treatment, is far different from adminis-
tering a standardized instrument as a stranger in the field.
In this report we describe and compare two techniques
by which we have classified the subjects in the MMAS re-
garding their erectile dysfunction status. These include the
original classification technique based on data from a sepa-
rate clinic sample and a new technique based on data from
the follow-up wave of the MMAS. The techniques have
been adapted to meet the rapidly evolving views and im-
proved understanding of erectile dysfunction in the clinical
community, while maintaining a balance between external
and internal validity.
 
2. Methods
 
2.1 Sampling and data collection
 
The baseline Massachusetts Male Aging Study was a
random sample, cross-sectional, multidisciplinary survey of
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health and aging in men, conducted in 11 cities and towns in
the area of Boston, MA. Communities were randomly se-
lected with probabilities proportional to population within
each of six strata defined by community size and median in-
come. Men born between 1917 and 1946 were drawn at ran-
dom from the annual state census listings. Sampling frac-
tions were adjusted to produce a uniform age distribution
between 40 and 70 years. Introductory letters were sent to
5287 men, followed by telephone recruitment. No financial
incentive was offered. Of 4104 successful telephone con-
tacts, 1526 men and 23 household members declined to co-
operate and 756 were deceased. A total of 1709 respondents
(53% of those eligible) enrolled in the study and completed
the in-home protocol. The MMAS participants were typi-
cally Caucasian (95%), employed (78%), and married
(75%). The low (5%) proportion of non-Caucasians is con-
sistent with the composition of the Massachusetts popula-
tion at the time of the sampling.
The follow-up phase of MMAS was conducted in 1995–
1997. Of the original 1709 participants, 180 were confirmed
deceased and 10 resided outside of the U.S.; 1156 were suc-
cessfully reinterviewed (76% of survivors living in the
U.S.). Protocols and instruments were adapted from base-
line with minimal deletions and refinements.
The field protocol of the MMAS has been previously de-
scribed [4–7]. Briefly, a trained interviewer visited each
subject in his home and completed the health questionnaire,
psychological instruments, physiological measurements,
and blood sampling. Weight, height, and blood pressure
were measured, and blood was drawn for analysis of lipids
and sex steroid hormones. A 23-item sexual activity ques-
tionnaire was self-administered in private and returned to
the interviewer in a sealed envelope [6].
 
2.2. Attribution of erectile function
 
The MMAS sexual activity questionnaire included questions
related to erectile function, but concentrated on specific
items (e.g., frequency of intercourse), rather than the global
subjective self-assessment of ED that was later formalized
by the NIH consensus conference [1]. To establish a relation
between the MMAS responses and a subject’s global self-
assessment of ED at baseline, we recruited a supplemental
sample of men presenting at the Boston University Medical
Center urology clinic during a 6-month period in 1990. Men
in this clinic sample were asked to complete a self-adminis-
tered questionnaire consisting of the MMAS questions and
one additional global question, reproduced here as Table 1.
Of 398 questionnaires distributed, 303 (76%) were re-
turned with complete responses. The clinic sample was se-
lected as a convenience sample for establishing the link be-
tween subjectively defined erectile dysfunction and the
MMAS instrument. No information was collected other
than the MMAS 23-item sexual activity questionnaire and
the single subjective assessment.
Quadratic discriminant analysis was used to calculate each
subject’s likelihood of having each of the four degrees of erec-
tile dysfunction, as described in Feldman 
 
et al
 
. [8] and Seber
[9]. The subject was assigned the degree of erectile dysfunction
into which he had the greatest probability of falling. These
assignments were used in MMAS baseline analyses to esti-
mate the prevalence of erectile dysfunction and its relation-
ship to age, health status, and behavior [4,10]. For the re-
mainder of the present article, we refer to these assignments
as the “clinic method” for attributing ED status at baseline.
The MMAS follow-up questionnaire on sexual activity
included the global, subjective, four-level self-assessment
of impotence shown in Table 1 as well as the original sexual
activity questionnaire. We therefore had the opportunity to
construct new discriminant formulae using internal data—
about the MMAS men themselves—rather than the external
sample of clinic patients employed in the clinic method.
Again, quadratic discriminant analysis was applied. As it
was with the clinic method, the resulting formula was then
applied to baseline data, providing an additional class as-
signment at baseline based on internal rather than external
calibration. This latter assessment is therefore an alternate
method of attributing ED status at baseline; we refer to this
as the “MMAS method” to emphasize its internal nature.
Agreement between two categorization methods was as-
sessed using the weighted kappa statistic [11,12]. Weighted
kappa is a statistic that awards full credit for agreement if
the two raters agree exactly on a subject’s rating, and dimin-
ishing partial credit for agreement as ratings diverge. The
precise amount of credit is determined by the weights,
which, as noted in Graham and Jackson [13], are somewhat
arbitrary. In the cases of the two kappas reported in this arti-
cle, the absolute error and squared-error weighted kappas
differed only in the hundredths digit. The reported kappas
use squared-error weights, which are the most commonly
reported. As recommended by Landis and Koch [14], a
kappa of 0.6 or greater is considered substantial. We also re-
port Pearson’s correlation coefficients as a measure of asso-
ciation.
 
3. Results
 
3.1. Description of the discriminant functions
 
As reported by Feldman et al. [8], the clinic method had
the following characteristics. It used nine questions, includ-
 
Table 1
Global question for self-rating of ED
IMPOTENCE means being unable to get and keep an erection that is rigid 
enough for satisfactory sexual activity. How would you describe yourself? 
(Circle one letter)
(a) Not impotent: always able to get and keep an erection 
good enough for sexual intercourse.
(b) Minimally impotent: usually able to get and keep an erection 
good enough for sexual intercourse.
(c) Moderately impotent: sometimes able to get and keep an erection 
good enough for sexual intercourse.
(d) Completely impotent: never able to get and keep an erection good 
enough for sexual intercourse.
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ing questions about how often the men had erections, sexual
intercourse or activity, whether they had trouble getting or
keeping an erection, how frequently they woke from sleep
with a full erection, whether their sexual activity was as fre-
quent as they wished, and several questions about their sat-
isfaction with their sex life and relationships. The questions
are presented in Table 2. Of the 1290 men classifiable using
the clinic method (75% of the total of 1709 men), 633
(49%) were classified as not at all impotent, 210 (16%)
were minimally impotent, 322 (25%) were moderately im-
potent, and 125 (10%) were completely impotent. Thus,
51% of the classifiable men were classified as having some
level of ED when using the clinic method.
The MMAS method used 13 questions, of which four
were indicators of missing values on four of the other items.
Appendix 1 summarizes the justification of this technique.
Of the questions used in the clinic method, the satisfaction
questions and the question about whether their sexual activ-
ity with a partner was as frequent as they desired were omit-
ted. These were omitted because they are not included in
validated clinical measures of ED [2,3] and because they re-
fer to a current partner, so that the question was not applica-
ble to men without partners. For example, one question in
the clinic method is:
How satisfied are you with your sexual relationship with
present partner or partners?
(a) Extremely satisfied.
(b) Somewhat satisfied.
(c) Neither satisfied nor dissatisfied.
(d) Somewhat dissatisfied.
(e) Extremely dissatisfied.
How might a man currently without a partner respond to
this question? Any two men might answer differently for
unpredictable reasons, and others would not respond at all.
Conceptually, then, it seemed advantageous to discard the
satisfaction questions. In addition, including the questions
did not add to the accuracy of the discriminant functions in
the sample used to generate the functions.
In their place were included questions about the fre-
quency of ejaculation during sex and during masturbation,
whether the subjects think that in general the interest in sex
declines as men get older, and how sexually aroused they
feel, relative to when they were adolescents. These ques-
tions were included because of their content validity and be-
cause their inclusion in forming the discriminant functions
led to more accurate formulae.
Additional covariates were tested for inclusion as well.
Of primary interest, we checked whether including age as a
covariate would improve the accuracy of the discriminant
functions. It did not. The fact that age did not improve the
discriminant analysis implies that the effect of aging was
adequately expressed through the specific symptoms in-
cluded in the analysis. The discriminant analysis was suc-
cessful, in the sense that the correlation between the dis-
criminant-function-based categorization and the subjective
self-assessment in the follow-up sample was 0.66 and the
 
Table 2
Sexual activity questions used in the construction of the two ED measures
Question
Clinic
method
MMAS
method
In an average month, how often do you have sexual intercourse or activity?
 
a
 
4 4
 
Missing frequency of sexual intercourse or activity question?
 
b
 
4
 
During an average 24-hour day, how often do you have a full hard erection?
 
a
 
4 4
 
Missing frequency of erections question?
 
b
 
4
 
During the last 6 months have you ever had trouble getting an erection before intercourse begins?
 
c
 
4 4
 
During the last 6 months have you ever had trouble keeping an erection once intercourse has begun?
 
c
 
4 4
 
How frequently do you awaken from sleep with a full erection?
 
d
 
4 4
 
How satisfied are you with your sex life?
 
e
 
4
 
How satisfied are you with your sexual relationship with present partner or partners?
 
e
 
4
 
How satisifed do you think your partner(s) is (are) with your sexual relationship?
 
e
 
4
 
Has the frequency of your sexual activity with a partner been as much as you desire, less than you desire, or more than you desire?
 
b
 
4
 
How often do you ejaculate by masturbation?
 
d
 
4
 
Missing ejaculate by masturbation question?
 
b
 
4
 
How often do you ejaculate in sex with a partner?
 
d
 
4
 
Missing ejaculate in sex with a partner question?
 
b
 
4
 
How do you feel about the following statement? “Men’s interest in sexual activity tends to decline as they get older: That is, the older 
you are the less interest you have in sexual matters.”
 
f
 
4
 
Compared to when you were an adolescent (around 18–20 years), do you feel sexually aroused?
 
g
 
4
 
a
 
Enter number in box.
 
b
 
Yes, No.
 
c
 
Yes, No, Have not had intercourse in last 6 months.
 
d
 
Scale form Daily to Not at all in the last six months.
 
e
 
Scale from 1 (extremely satisifed) to 5 (extremely dissatisfied).
 
f
 
Scale from 1 (completeley agree) to 5 (completely disagree).
 
g
 
More than when an adolescent, About the same as when an, Less than when an adolescent.
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weighted kappa showed a substantial agreement of 0.66. In
addition, 90% of subjects were correctly classified (66%) or
were classified to an adjacent category (24%), so that only
10% in total were misclassified from none to moderate (2%)
or complete (1%), minimal to complete (1%), moderate to
none (1%), or complete to minimal (2%) or none (3%).
The 13 questions used in the MMAS method are pre-
sented in Table 2. As summarized in Table 3, of the 1626
subjects who were classified (95% of the 1709 men), 917
(56%) were classified as not at all impotent, 380 (23%)
were minimally impotent, 127 (8%) were moderately impo-
tent, and 202 (12%) were classified as completely impotent.
Thus, under the MMAS method, 44% of the subjects were
classified as having some level of ED. Appendix 2 contains
more technical details regarding discriminant analysis and
the SAS [15] code used to carry it out.
In Table 3 we present information summarizing the as-
signments made by the two methods. A summary statistic
for each contributory variable is presented for each assigned
group. For example, we see that using the clinic method, the
men who were classified as having no impotence had sexual
activity or intercourse an average of 8.4 times per month.
Those classified as minimally impotent had sexual activity
8.0 times per month on average, those classified as moder-
ately impotent 4.9 times per month, and the completely im-
potent had sexual activity 2.6 times per month. The MMAS
method found mean amounts of sexual activity per month
were 8.6, 6.9, 3.7, and 1.6 for those classified as not impo-
tent, and minimally, moderately, and completely impotent,
respectively.
 
3.2. Comparing the two techniques
 
In this section we summarize numerical comparisons of
the two techniques. One primary result seen in Table 3 is
that the MMAS method was able to classify 1626 men, 26%
more than the 1290 classifiable with the clinic method.
Thus, the MMAS classified 95% of the 1709 men, while the
clinic method classified 75%. Another striking difference is
that the “Moderately impotent” group, which was the sec-
ond largest using the clinic method, is now the smallest. In
contrast, the proportion of men who are completely impo-
tent increased slightly. The minimally impotent group had
the largest proportional increase, nearly doubling in size
even though the total classifiable sample increased by only
about a quarter. Overall, the proportion of men classified as
having some degree of impotence (minimal, moderate, or
complete) decreased from 51% to 44%.
In Table 4, we show how the 1709 men were classified
using both methods. In summary, 4.0% of men could not be
classified by either method. In total 351 (20.6%) of the men
could not be classified using the clinic method but were
classifiable with the MMAS method. Of these, 43.6% were
classified as not impotent, 14.1% as minimally impotent,
 
Table 3
Sexual activity activity profile of Massachusetts Male Aging Study men: grouped by assigned degree of erectile dysfunction based on two methods 
of assignment
Assigned degree of erectile dysfunction
None Minimal Moderate Complete
Clinic method: 1290 subjects classifiable
Subjects 633 (49%) 210 (16%) 322 (25%) 125 (10%)
Sexual activity (mean frequency/mo) 8.4 8.0 4.9 2.6
Full erection (median frequency/mo) 30 30 12 3
Awaken with erection (median frequency/mo) 8–12 8–12 2–3
 
,
 
1
Satisfied with frequency of activity (%) 67 67 32 30
Satisfaction with sex life
 
a
 
1.7 2.2 2.8 3.9
Satisfaction with partner
 
a
 
1.7 2.0 2.8 3.4
Partner’s satisfaction
 
a
 
1.6 2.0 2.6 3.5
MMAS method: 1626 subjects classifiable
Subjects 917 (56%) 380 (23%) 127 (8%) 202 (12%)
Sexual activity (mean frequency/mo) 8.6 6.9 3.7 1.6
Missing sexual activity question (%) 0 2 2 11
Full erection (median frequency/mo) 30 30 4 0
Missing full erection question (%) 0 5 9 12
Awaken with erection (median frequency/mo) 8–12 8–12 1 0
 
b
 
No ejac. during masturbation in last 6 mo (%) 21 20 50 38
Missing ejac. during masturbation quest. (%) 19 23 2 18
No ejac. during intercourse in last 6 mo (%) 12 9 22 44
Missing ejac. during intercourse quest. (%) 16 14 17 53
“Men’s interest declines”
 
a
 
3.3 3.2 2.6 2.7
Less aroused than when adolescent? (%) 55 71 89 86
 
a
 
Mean on scale from 1 (completely agree) to 5 (completely disagree).
 
b
 
Not at all in last 6 months.
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6.8% as moderately impotent, and 35.4% completely impo-
tent. Thus, these men were disproportionately from the
completely impotent group.
As shown in Table 4, 1275 men received a classification
under both methods. Over two-thirds (68.5%) of these men
received the same assessment under both methods. In addi-
tion, 27.2% of the men classifiable using both methods were
classified as having a greater degree of ED using the clinic
method. In contrast, only 4.3% of those classifiable using
both methods were classified as having a greater degree of
ED using the MMAS method than the clinic method. The
correlation between the two methods was 0.53 and the
weighted kappa was 0.49.
One interesting observation to be made from Table 4 is
that of the 125 men classified as completely impotent using
the clinic method, 63 were classified as not at all impotent
using the MMAS method. Further investigation showed that
of these men, all but two reported ejaculation during either
sex or masturbation at least once during the last 6 months.
Only two men in this group of 63 reported neither erections
nor sexual activity in an average day or week, respectively.
None of these men reported having trouble getting or keep-
ing an erection.
The results of some comparative analyses useful in as-
sessing construct validity are presented in Table 5. In Table
5, we show the results of cross-sectional logistic regressions
predicting ED state at time 1 using covariates measured at
time 1. Here ED is dichotomized as none or minimal vs.
moderate or complete. Each row represents a different cova-
riate, named in column 1. In column 2 we show the odds ra-
tio and 95% confidence interval (CI) associated with the
predictor using the clinic method of generating the outcome
variable. In column 3, we show the odds ratio and 95% CI
for the MMAS method.
The covariates considered include age (for which the
odds ratio is expressed for a 10-year increase in age), cur-
rent cigarette smoking, presence or absence of diabetes by
self-report, presence or absence of high blood pressure by
self-report, and presence or absence of depression assessed
by a score of 16 or greater on the CES-D [16,17]. All of
these factors have been identified in previous research as
possible risk factors for ED [18–22]. For two of the six
items, age and smoking, the MMAS method generated a
substantially stronger association than the clinic method.
For the relationship between smoking and ED, the confi-
dence interval for the odds ratio generated by the clinic
method included 1, but the confidence interval for the
MMAS method excluded 1. Thus, using the clinic definition
of ED, one would arrive at a different conclusion than if the
MMAS method were used. In addition, the effect of age was
much stronger using the MMAS method, and the confi-
dence intervals for two odds ratios generated by the two
methods did not overlap. For the four medical conditions,
the MMAS and clinic methods were roughly equivalent.
Both methods resulted in positive associations with ED,
consistent with the existing literature.
Finally, in another age comparison, we found that 7.04%
of 40–50-year-old men were classified as completely impo-
tent using the clinic method vs. only 4.52% using the
MMAS method. Among the 50–60-year-old men, the rates
were 8.56% and 8.39%, using the clinic and MMAS meth-
ods, respectively. Thus, the rate was nearly constant over
that 20-year range when using the clinic method, but shows
a sizeable increase when using the MMAS method. Among
men aged 60–70, the rates were 14.32% (clinic) and 24.95%
(MMAS) using the two methods.
 
4. Discussion
 
The fact that the two methods showed different associa-
tions with covariates and the fact that the weighted kappa
 
Table 4
Assignment status of 1709 men based on clinic and MMAS methods
Clinic method
MMAS method Missing None Minimal Moderate Complete All
Missing 68 (4.0) 6 (0.4) 0 (0) 5 (0.3) 4 (0.2) 83 (4.9)
None 153 (9.0) 596 (34.9) 41 (2.4) 64 (3.7) 63 (3.7) 917 (53.7)
Minimal 49 (2.9) 7 (0.4) 162 (9.5) 156 (9.1) 6 (0.4) 380 (22.2)
Moderate 24 (1.4) 0 (0) 6 (0.4) 80 (4.7) 17 (1.0) 127 (7.4)
Complete 125 (7.3) 24 (1.4) 1 (0) 17 (1.0) 35 (2.0) 202 (11.8)
All 419 (24.5) 633 (37.0) 210 (12.3) 322 (18.8) 125 (7.3) 1709 (100)
 
N
 
, (%) of 1709 total subjects.
Table 5
Cross-sectional associations of select covariates with erectile dysfunction 
estimated by logistic regression from the baseline phase of Massachusetts 
Male Aging Study (1987–1989)
Covariate
Clinic method OR 
(95% CI)
MMAS method OR 
(95% CI)
Age 1.57 (1.37, 1.81) 2.56 (2.18, 3.02)
Smoking 0.94 (0.72, 1.22) 1.39 (1.07, 1.80)
Diabetes 2.67 (1.73, 4.16) 2.96 (2.01, 4.32)
Hypertension 1.78 (1.39, 2.28) 1.47 (1.14, 1.89)
Heart disease 2.67 (1.90, 3.77) 2.53 (1.83, 3.45)
Depressive symptoms 2.03 (1.39, 2.96) 1.85 (1.30, 2.59)
Odds ratio (OR) in favor of erectile dysfunction (moderate or com-
plete). For age, OR expressed per 10-year interval; for other covariates, OR
for presence of attribute in relation to absence of attribute.
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indicated a less-than-substantial agreement between the two
methods are evidence that they have different meanings.
Presented with these two alternative methods, the natural
question is: Which one is preferable? Because we do not
know the true ED status of the men at baseline, we cannot
determine which method is more valid (i.e., closer to the
truth). In other words, we cannot directly assess the criterion
validity of either approach. Instead, we can only describe
which method performs better given the available evidence.
The arguments supporting the MMAS method can be
summarized as follows: (1) the baseline sample is more
similar to the follow-up sample than to the clinic sample, (2)
the MMAS method retains more data than the clinic method,
and (3) the MMAS method has better construct validity. A
detailed discussion of each of these arguments follows.
 
4.1. Samples more similar
 
Unfortunately, the clinic data set does not include infor-
mation on important covariates, such as age. If these were
included, we could compare the characteristics of the clinic
sample to the MMAS sample at baseline and determine
whether the two samples were similar. Given the self-selected
nature of the clinic sample, it is likely that they were differ-
ent from the population-based MMAS sample on factors
such as health status and age. In addition, we do not know
why they chose to go to the clinic. In fact, in using the clinic
method, we incorporate some selection bias; we are apply-
ing the results from a self-selected (clinic) sample to the
general (randomly selected MMAS) population. The
MMAS men at follow-up are also somewhat selected in that
they are survivors and were available for follow-up; how-
ever, it certainly seems plausible that despite being 8 years
older, they may be more similar to the MMAS men at base-
line than are the clinic men.
One important difference between the clinic sample and
the general population is that in presenting at a urology
clinic, they may have already perceived that they had ED
and decided to seek help. Only a small proportion of men
with ED seek medical treatment, because of a reluctance to
admit a problem, a belief that loss of function is an inevita-
ble consequence of aging, or inadequate knowledge of ther-
apeutic options [6]. Thus, men seeking treatment may iden-
tify as ED the same symptoms that randomly selected men
would not. Alternatively, they may be younger on average
than the randomly selected men. Older men are more likely
to be satisfied with the same objective poor performance
than younger men [6]. This might make younger men more
likely to visit a clinic, and would mean that they would be
more likely to interpret their symptoms as ED than a man in
the MMAS sample.
In either case, we would expect that the clinic method
would generate a more severe diagnosis for a randomly se-
lected man than he would for himself. In fact, in comparing
the two methods, we see that the clinic method did indeed
attribute a larger proportion of men as having some level of
dysfunction. It also categorized a larger proportion of men
as having moderate or complete ED; it classified 27.2% of
the men as having a greater degree of ED than the MMAS
method did.
 
4.2. Practical missing data considerations
 
The clinic method generated an ED state for 75% men
assessed at baseline. The remainder were missing one or
more of the nine questions that are used in the method. In
contrast, the MMAS method generated values for 95% of
the men. Thus, using the clinic method would violate the
general principle of retaining as many subjects as possible.
In addition, using the clinic method would also represent
another type of self-selection of the sample, because men
who chose to answer all nine questions in the clinic method
may be different from men who chose not to answer one or
more of the questions. For example, the MMAS classifica-
tions of the men who were not classifiable with the clinic
method suggests that the clinic method may have failed to
classify some of the most affected men. In other words, the
MMAS method would allow us to keep more men in the
study, preserve more of the randomly sampled nature of the
MMAS men, and classify more men who were severely af-
fected.
 
4.3. Better construct validity
 
We would expect that the preferable imputation method
would result in stronger associations with possible corre-
lates of ED, but also remain consistent with existing knowl-
edge. Our results show that the MMAS method produced a
stronger overall age–ED association than did the clinic
method, and also a more credible increasing trend with age.
The age–ED association is well documented in the literature
[1]. Recent findings have shown that cigarette smoking is an
independent predictor of ED among middle-aged men [18].
The MMAS method produced a statistically significant pos-
itive relationship between current cigarette smoking and
ED, while the clinic method did not. Associations between
ED and chronic medical conditions such as heart disease,
hypertension, and diabetes were consistent with the litera-
ture using both methods.
Finally, the associations with the constituent questions
were more plausible using the MMAS method. Nearly all of
the men who moved from the most affected category under
the clinic method to the least affected category under the
MMAS method were able to ejaculate, had either erections
or sexual activity, and had no trouble getting or keeping
erections. Thus, the clinic method assignment to the com-
pletely impotent group for these men seems highly suspect;
the MMAS method assignment to the not at all impotent
groups seems plausible.
It should be noted that the utility of either technique de-
pends on the desirability of a subjective assessment of ED,
as expressed in the NIH consensus panel [1]. Many men
who perceive themselves to be impotent eventually receive
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clinical diagnoses of premature ejaculation, retarded or-
gasm, decreased libido, or even infertility. We attempt to
minimize errors of this sort by defining the answers to the
single subjective question, as shown in Table 1. While com-
parisons with clinical questionnaires [2,3] are ongoing, we
use the answers to the single subjective question as the gold
standard without assessing the relationship between the sin-
gle question and clinical diagnosis.
 
5. Summary
 
The epidemiology of erectile dysfunction is a rapidly de-
veloping field of study; it is often the case that rich and
valuable data sets do not contain a measure that turns out to
be of later interest. In this case, definitions of ED changed
during the course of the MMAS. In addition, over time,
thinking about the causes of ED has shifted from attributing
ED primarily to psychogenic causes to attributing ED to or-
ganic causes, and it is now well-accepted that ED can be as-
sessed subjectively. Assessment of ED in a field setting or
in a population-based study have rarely been addressed:
there is still no “gold standard” for defining ED. In the
MMAS, we have developed a new method of classifying
men according to a standard that did not yet exist when the
study was designed.
This method is not intended to replace existing instru-
ments. If validated with an external sample, it could be used
in large population-based studies where it is impractical or
inappropriate to include these instruments. If the method
were thus shown to be generalizable to other studies, it
would be much more valuable.
We have developed an improved method of defining ED
in a population-based epidemiological study. The MMAS
method is less susceptible to selection bias, results in less
missing data, and has greater construct validity than the pre-
viously described method based on external data [8]. Al-
though this changes our original estimates of epidemiologic
parameters of ED, it represents an improvement, a refine-
ment, over our own previous results.
 
Appendix 1
 
The missing data procedure
 
In this appendix we show why the approach to the miss-
ing data that we have taken is appropriate.
As shown in Table 2, questions that include a missing
data indicator variable (questions 1, 3, 8, and 10) are ex-
pressed as two separate variables. For example, the fre-
quency of sexual activity question is:
(1) In an average week, how often do you have sexual in-
tercourse or activity? (Enter number in box.)
This question is missing for 4% of the men at time 1. The
mean answer among men who answered this question is
 
2.13. For the men who did not answer this question, we in-
sert this mean, 2.13.
We augment the data by including the following question:
(2) Missing frequency of sexual intercourse or activity
question (1)?
(a) No.
(b) Yes.
For those men who were missing the frequency question,
the answer to this question takes the value 1, for those who
answered the frequency question, the answer takes the value 0.
While this type of procedure can lead to incorrect vari-
ances when parameter estimates are of interest, no error in
prediction is caused, in a sense described below. In this
case, we are interested solely in prediction, so our results
will not suffer from error.
The heuristic logic for this result can be easily seen in the
context of ordinary least squares regression with an indica-
tor variable (i.e., ANCOVA). First, suppose that we have a
simple linear regression with one continuous predictor. To
concretize this, suppose the regression equation is:
(1)
in this case, the predicted value for a subject 
 
i
 
 is 
 
i
 
 
 
5
 
  
 
1
 
x
 
i
 
 where ,  can be found from the usual regression re-
sults. Suppose an observation 
 
j
 
 were added to the data set
that had a value 
 
x
 
j
 
 equal to the mean of the original sample
of 
 
x
 
’s and any arbitrary value 
 
y
 
j
 
. If the regression model Eq.
(1) were fit again with this extra observation, the estimated
slope 
 
j
 
 would be equal to the original slope . If an indica-
tor variable 
 
z
 
 were included that took a value of 0 for the
original subjects and a value of 1 for subject 
 
j
 
, we could
write another regression equation as
(2)
where a superscript 
 
j
 
 indicates that observation 
 
j
 
 is included
in the analysis. In this case, not only is 
 
j
 
 
 
5
 
  but also 
 
j
 
 
 
5
 
. So for an observation in the original data set (i.e., any ob-
servation other than 
 
j
 
) the predicted value 
 
i
 
 from Eq. (2) is
still  
 
1
 
 
 
x
 
i
 
, because 
 
z
 
i
 
 
 
5
 
 0. In other words, the prediction
is unchanged by adding the additional observation. This will
be true regardless of how many observations are added. The
application of this result to the missing data case is obvious.
[We repeat here that the variances of the parameter esti-
mates will be affected by this technique, i.e., Var( ) 
 
Þ
 
Var(
 
j
 
). This missing data technique is applicable when the
purpose is simply prediction of new values, but is not appro-
priate for inference about parameter estimates.]
A simpler way of thinking about this is that because the
imputed values are all at the mean of the observed values,
they do not affect the slope that would be observed using
only the observed values. And the imputed values do not af-
fect the intercept because they get their own intercept from
the missing value indicator.
This technique is desirable in that it allows the maximum
number of subjects to be retained and yet allows completely
y a b x+=
yˆ aˆ
bˆ aˆ bˆ
bˆ bˆ
y j a j b j x j g jz j+ +=
bˆ bˆ aˆ
aˆ
yˆ
aˆ bˆ
bˆ
bˆ
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observed subjects to retain the predicted value they would
have received if the subjects missing values had been ex-
cluded. This result carries through for discriminant analysis.
 
Appendix 2
 
SAS code used to perform the discriminant analysis for the 
MMAS method
 
This is the SAS code for the MMAS method:
proc discrim method
 
5
 
normal pool
 
5
 
test crossvalidate
posterr outstat
 
5
 
calib;
class ed4;
priors proportional;
var sexmo_2 sexmo_2m erctda_2 ertda_2m tblbef_2
tbldur_2 full_2
ejacm ejacm_m ejacs ejacs_m intrst_2 adol;
run;
In brief, the analysis computes the generalized distance
between an observation and each of the group means. A
simple function of these distances are then normalized to
sum to one; this results in the probability that the observa-
tion comes from the group. Computing the generalized dis-
tance requires a matrix function involving the estimated
variance–covariance matrix in each of the four groups. This
function involves 104 parameters for each group (13 mea-
sures of central tendency and 91 unique elements from the
13 
 
3
 
 13 variance–covariance matrix). Thus, for reasons of
complexity and space, we do not offer more specific details
about the discriminant functions here. For readers who are
interested, we will provide the details of the discriminant
functions via e-mail.
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